Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in
hair loss, that affects up to 2% of the general population. The exact pathobiology of AA has …

Patients suffering from alopecia areata (AA) can lose hair in focal regions, the complete
scalp, including eyelashes and eyebrows, or even the entire body. The exact pathology is …

Background Alopecia areata is an autoimmune condition characterized by rapid hair loss in
the scalp, eyebrows, and eyelashes, for which treatments are limited. Baricitinib, an oral …

Background There are no treatments approved by the Food and Drug Administration for
alopecia areata. Objective To evaluate the efficacy and safety of baricitinib in patients with≥ …

Alopecia areata (AA) is a relatively common nonscarring hairloss disease characterized by
an autoimmune response to anagen hair follicles (HFs). Accumulated evidence suggests …

Alopecia areata is an autoimmune hair loss disease that is non-scarring and is
characterized by chronic inflammation at the hair follicle level. Clinically, patients' …

Background Alopecia areata (AA) is characterized by hair loss that can affect the scalp and
body. This study describes the psychosocial burden of AA. Methods Participants diagnosed …

Background Content‐valid and clinically meaningful instruments are required to evaluate
outcomes of therapeutic interventions in alopecia areata (AA). Objectives To develop an …

Background Eyebrow and eyelash hair loss and nail damage—in addition to scalp hair loss—
are important signs/symptoms of alopecia areata (AA) to patients and deserve assessment …

Purpose Alopecia areata (AA) is a common disorder of patchy hair loss which carries a
substantial psychological burden for patients. The current understanding of AA prevalence …